Nektar Therapeutics (NKTR) News Today $29.37 +1.37 (+4.90%) As of 10:26 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock NKTR Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Nektar Therapeutics (NASDAQ:NKTR) Insider Mark Andrew Wilson Sells 676 Shares2 hours ago | insidertrades.comNektar Therapeutics: Fairly Valued, High-Quality Biotech With Multiple Near-Term Catalysts4 hours ago | seekingalpha.comORIC Pharmaceuticals Appoints Kevin Brodbeck, PhD, as Chief Technical Officer to Support Advancement into Late-Stage Clinical DevelopmentAugust 18, 2025 | quiverquant.comQNektar Therapeutics (NASDAQ:NKTR) Position Trimmed by XTX Topco LtdAugust 18, 2025 | marketbeat.comNektar Therapeutics’ Earnings Call Highlights Growth PotentialAugust 14, 2025 | theglobeandmail.comNektar Therapeutics (NASDAQ:NKTR) Shares Sold by Altium Capital Management LLCAugust 14, 2025 | marketbeat.comPrimecap Management Co. CA Decreases Position in Nektar Therapeutics (NASDAQ:NKTR)August 9, 2025 | marketbeat.comNektar Therapeutics (NKTR) Q2 2025 Earnings Call TranscriptAugust 8, 2025 | seekingalpha.comWhy Nektar Therapeutics Stock Popped 6% on FridayAugust 8, 2025 | fool.comNektar Therapeutics Reports Q2 2025 Financial ResultsAugust 8, 2025 | msn.comCautious Hold Rating on Nektar Therapeutics Amid Promising Yet Uncertain Clinical DevelopmentsAugust 8, 2025 | tipranks.comNektar (NKTR) Q2 Revenue Falls 52%August 8, 2025 | fool.comNektar Therapeutics Reports Second Quarter 2025 Financial ResultsAugust 7, 2025 | prnewswire.comCM Management LLC Increases Holdings in Nektar Therapeutics (NASDAQ:NKTR)August 6, 2025 | marketbeat.comNektar Therapeutics (NASDAQ:NKTR) Shares Acquired by Mackenzie Financial CorpAugust 6, 2025 | marketbeat.comNektar Therapeutics (NASDAQ:NKTR) Stake Reduced by Bank of New York Mellon CorpAugust 6, 2025 | marketbeat.comNektar Gears Up to Report Q2 Earnings: What's in the Cards?August 4, 2025 | msn.comNektar Therapeutics (NASDAQ:NKTR) is a favorite amongst institutional investors who own 53%August 4, 2025 | finance.yahoo.comNektar Therapeutics (NASDAQ:NKTR) Receives Consensus Rating of "Moderate Buy" from BrokeragesAugust 3, 2025 | marketbeat.comNektar Therapeutics (NKTR) to Release Earnings on ThursdayAugust 2, 2025 | marketbeat.comNektar Therapeutics (NASDAQ:NKTR) Shares Bought by Cwm LLCAugust 2, 2025 | marketbeat.comNektar to Announce Financial Results for the Second Quarter on Thursday, August 7, 2025, After Close of U.S.-Based Financial MarketsJuly 31, 2025 | prnewswire.comCerity Partners LLC Invests $52,000 in Nektar Therapeutics (NASDAQ:NKTR)July 31, 2025 | marketbeat.comMonaco Asset Management SAM Trims Stock Position in Nektar Therapeutics (NASDAQ:NKTR)July 30, 2025 | marketbeat.comNektar gets FDA fast track status for alopecia areata drugJuly 29, 2025 | msn.comNektar Therapeutics Receives Fast Track Designation for Rezpegaldesleukin for the Treatment of Severe-to-Very Severe Alopecia AreataJuly 29, 2025 | prnewswire.comDeuterium Capital Management LLC Invests $381,000 in Nektar Therapeutics (NASDAQ:NKTR)July 29, 2025 | marketbeat.comNektar Therapeutics (NKTR) Announced Positive results for RezpegaldesleukinJuly 29, 2025 | finance.yahoo.comNektar Therapeutics (NASDAQ:NKTR) Stock Price Crosses Above 200 Day Moving Average - Here's What HappenedJuly 24, 2025 | marketbeat.com3 Bullish Biotech Stocks With Explosive Growth Trends (NKTR)These small-cap biotech stocks offer high-reward potential with bullish momentum and key catalysts ahead in urology, autoimmune, and gene editing therapies...July 21, 2025 | marketbeat.comResearch Analysts Set Expectations for NKTR FY2025 EarningsJuly 16, 2025 | marketbeat.comWealth Enhancement Advisory Services LLC Purchases New Shares in Nektar Therapeutics (NASDAQ:NKTR)July 12, 2025 | marketbeat.comQ2 EPS Estimate for Nektar Therapeutics Reduced by AnalystJuly 10, 2025 | marketbeat.comNektar Therapeutics (NASDAQ:NKTR) Shares Sold by Peapod Lane Capital LLCJuly 10, 2025 | marketbeat.com49 Wealth Management LLC Buys New Holdings in Nektar Therapeutics (NASDAQ:NKTR)July 9, 2025 | marketbeat.comB. Riley Raises Nektar Therapeutics (NASDAQ:NKTR) Price Target to $85.00July 8, 2025 | marketbeat.comNektar Therapeutics (NASDAQ:NKTR) Receives Consensus Rating of "Buy" from BrokeragesJuly 8, 2025 | marketbeat.comNektar Therapeutics Reports Positive Phase 2b Results for Eczema Treatment RezpegaldesleukinJuly 6, 2025 | msn.comWhy Nektar Therapeutics Stock Dived by 3% TodayJuly 3, 2025 | fool.comWhat is Zacks Research's Estimate for NKTR FY2025 Earnings?July 3, 2025 | marketbeat.comNektar Therapeutics Announces Closing of $115 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional SharesJuly 2, 2025 | prnewswire.comQ2 EPS Estimate for Nektar Therapeutics Lowered by AnalystJuly 2, 2025 | marketbeat.comNektar Therapeutics Announces Public Offering of SharesJuly 1, 2025 | tipranks.comNektar Therapeutics stock dips after pricing $100M stock offeringJuly 1, 2025 | seekingalpha.comNektar Therapeutics Announces Pricing of $100 Million Public OfferingJuly 1, 2025 | prnewswire.comNektar Therapeutics launches proposed public offeringJune 30, 2025 | msn.comNektar Therapeutics stock falls after announcing public offeringJune 30, 2025 | in.investing.comNektar Therapeutics Announces Proposed Public OfferingJune 30, 2025 | prnewswire.comBiotech Catalyst Alert: NKTR, CDTX & WGS Rallying With Big GainsWith major rallies and analyst backing, Nektar, Cidara, and GeneDx are drawing interest; will these biopharma firms maintain their growth trajectories?June 30, 2025 | marketbeat.comNektar Jumps 157% on Drug Trial Data-Can It Go Even Higher?June 28, 2025 | msn.com Get Nektar Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NKTR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Videos NKTR Media Mentions By Week NKTR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NKTR News Sentiment▼1.550.54▲Average Medical News Sentiment NKTR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NKTR Articles This Week▼75▲NKTR Articles Average Week Get Nektar Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NKTR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PCRX News Today OMER News Today ASMB News Today CPIX News Today LLY News Today JNJ News Today ABBV News Today MRK News Today PFE News Today BMY News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NKTR) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersSilver’s Still Under $35… For Now.Silver is trading around $33—but insiders are betting on a $70 breakout by year’s end. With supply shrinkin...GoldenCrest Metals | SponsoredI trusted Trump and got screwedPorter Stansberry says he got one thing wrong—and now millions of Americans could pay the price. After warning...Porter & Company | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredUS attacks China, September 30?The White House just ordered more than 400 government agencies to prepare for the next phase of America’s econ...Stansberry Research | SponsoredOne tiny company just cracked Google’s $19B problemGoogle’s AI-powered search could cost $20 billion a year in electricity—nearly half its profits. But new resea...True Market Insiders | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nektar Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share Nektar Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access